arrow
J

Juan E. Camacho Londoño

CSL Innovation GmbH
H指数:14
被引数:940

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of Topical Reconstituted HDL as a Treatment for Diabetic Wounds in Murine and Porcine Models

重组HDL局部给药在糖尿病伤口治疗中的评估:基于小鼠和大猪模型

2026-08-140
OA
PO22 Single-cell Transcriptomics Identify Calcium Overload and a Pro-fibrotic Macrophage Program as Drivers of Pathological Remodeling in a Model of Catecholaminergic Cardiomyopathy

PO22 单细胞转录组学鉴定钙过载和一种促纤维化巨噬细胞程序作为儿茶酚胺心肌病模型中病理性重塑的驱动因素

2026-03-190
OA
Novel Peptide Therapeutics Targeting the L-Type Calcium Channel Prevent Hypertrophic Cardiomyopathy by Decreasing Mitochondrial Energetics

靶向L型钙通道的新型肽类疗法通过降低线粒体能量代谢来预防肥厚型心肌病

2025-08-270
OAAI
TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia

TRPC5控制肾上腺素介导的低血糖反调节

2024-10-072
PRE
OCaR1 endows exocytic vesicles with autoregulatory competence by preventing uncontrolled Ca2+ release, exocytosis, and pancreatic tissue damage
2024-04-011
OAAI
An endo-lysosomal Ca2+ store in cardiomyocytes controlled by OCaR proteins determines fatal tachyarrhythmias
2022-12-010
PRE
A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway

组蛋白去乙酰化酶4的蛋白水解片段通过调节己糖胺生物合成途径保护心脏免于衰竭

2017-12-1197
PREAI
A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling
2015-06-1188
OAAI